ArticleESMO gastrointestinal oncology2025

Analysis of fruquintinib in patients with metastatic colorectal cancer who were enrolled in Spain: results from the global FRESCO-2 study.

R Garcia-Carbonero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.